DELFLEX A PERITON.DIAL.SOLN. W.2.5% DEXTROSE 15.2 MG / 100 ML
MAGNESIUM CHLORIDE : 15.2 MG / 100 ML SODIUM CHLORIDE : 567 MG / 100 ML DEXTROSE : 2.5 G / 100 ML CALCIUM CHLORIDE : 25.7 MG / 100 ML SODIUM LACTATE : 392 MG / 100 ML · DIN 02025485 · FRESENIUS USA MANUFACTURING INC
Health Canada status: CANCELLED POST MARKET
What is DELFLEX A PERITON.DIAL.SOLN. W.2.5% DEXTROSE?
DELFLEX A PERITON.DIAL.SOLN. W.2.5% DEXTROSE 15.2 MG / 100 ML contains MAGNESIUM CHLORIDE : 15.2 MG / 100 ML SODIUM CHLORIDE : 567 MG / 100 ML DEXTROSE : 2.5 G / 100 ML CALCIUM CHLORIDE : 25.7 MG / 100 ML SODIUM LACTATE : 392 MG / 100 ML. It is listed in the Health Canada Drug Product Database under DIN 02025485, held by FRESENIUS USA MANUFACTURING INC, supplied as SOLUTION for INTRAPERITONEAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Jul-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02025485 |
|---|---|
| Brand name | DELFLEX A PERITON.DIAL.SOLN. W.2.5% DEXTROSE |
| Generic / active ingredient | MAGNESIUM CHLORIDE : 15.2 MG / 100 ML SODIUM CHLORIDE : 567 MG / 100 ML DEXTROSE : 2.5 G / 100 ML CALCIUM CHLORIDE : 25.7 MG / 100 ML SODIUM LACTATE : 392 MG / 100 ML |
| Manufacturer | FRESENIUS USA MANUFACTURING INC |
| Strength | 15.2 MG / 100 ML |
| Dosage form | SOLUTION |
| Route of administration | INTRAPERITONEAL |
| Schedule | Ethical |
| ATC code | B05DB HYPERTONIC SOLUTIONS |
| AHFS class | 40:36.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Jul-2016 |
| Original market date | 1994-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B05DB HYPERTONIC SOLUTIONS. 3 of 21 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BALANCE 1.5% GLUCOSE, 1.25 MMOL/L CALCIUM | 0.1838 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | MARKETED | DIN 02261057 |
| BALANCE 2.3% GLUCOSE, 1.25 MMOL/L CALCIUM | 0.1838 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | MARKETED | DIN 02261073 |
| BALANCE 4.25% GLUCOSE, 1.25 MMOL/L CALCIUM | 0.1017 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | MARKETED | DIN 02261065 |
| BALANCE 1.5% GLUCOSE, 1.75 MMOL/L CALCIUM | 0.2573 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | APPROVED | DIN 02261022 |
| BALANCE 2.3% GLUCOSE, 1.75 MMOL/L CALCIUM | 0.2573 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | APPROVED | DIN 02261049 |
| BALANCE 4.25% GLUCOSE, 1.75 MMOL/L CALCIUM | 0.1017 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | APPROVED | DIN 02261030 |
| BICAVERA 1.5% GLUCOSE | 0.2573 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | CANCELLED PRE MARKET | DIN 02299682 |
| BICAVERA 2.3% GLUCOSE | 25.0 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | CANCELLED PRE MARKET | DIN 02299690 |
| BICAVERA 4.25% GLUCOSE | 5.786 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | CANCELLED PRE MARKET | DIN 02299704 |
| BICAVERA FORTE 1.5% GLUCOSE | 0.3675 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | CANCELLED PRE MARKET | DIN 02269384 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for DELFLEX A PERITON.DIAL.SOLN. W.2.5% DEXTROSE
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.